In a RegMedNet post today (March 9, 2016), Asymmetrex explains that, although much attention is given to molecular genetics advances in the efficiency and integrity of new technologies for gene therapy, failure to count tissue stem cells is likely to limit future treatment success. Sufficient genetic engineering and transplantation of targeted tissue stem cells, like
In Upcoming Webinar and Conferences, Asymmetrex Will Intensify Education on Counting Adult Tissue Stem Cells For Regenerative Medicine and Drug Development As 2015 drew to a close, stem cell medicine biotechnology start-up company Asymmetrex began an effort to educate the pharmaceutical and regenerative medicine industries on the value of counting adult tissue stem cells. The
Cliches abound to describe the “unique” properties of adult tissue stem cells. The lay publications of the National Institutes of Health are full of them. “Self-renew.” “Differentiate.” “Multipotent.” The problem with lazy cliches is that they often understate and distort the calming and terrifying beauty of life. The life of adult stem cells is no
With its recently described improved technologies for specifically identifying adult tissue stem cells or detecting their function by a computer simulation technology, biotech start-up Asymmetrex is anticipating a need for rules to move the field of stem cell biology from a past of common errors and misconceptions to a future of exact quantification. Asymmetrex’s 5
As ideas on the potential ability of some adult tissue stem cells to accelerate repair of damaged or injured tissues have grown to be more widely disseminated, so has interest grown in developing stem cell treatments within standard medical practice. In particular, chronic debilitating ailments like joint pain and low back pain, caused either by
With the tsunami of research on pluripotent stem cells induced by a 2012 Nobel Prize, in the past several years, adult tissue stem cells experienced a major loss of interest and research effort. Yet, the greatest progress in stem cell medicine is still due to, in some cases well-known and in other cases not so
Ad Hoc Stem Cell Medical Research? Eight General Principles For Its Advance Stem cell medicine has a new rapidly moving frontier of research and treatment activity. To help keep that frontier from getting too wild, stem cellbiologist and physician scientist James Sherley recently teamed up with Boston Biolife to provide continuing stem cell medical education
Adult tissue stem cells have a growing list of current and potential medical applications, including drug development; gene therapy; bone marrow or corneal restoration; treatments for low back pain and other degenerative joint diseases; treatments for heart attack and stroke; treatment for chronic illnesses like multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS); treatment for
Since the beginnings of the field of stem cell biology, more than half a century ago, it has not been possible to count adult tissue stem cells in experimental and clinical preparations. This surprising, but widely known, situation exists because, although tissue stem cells are unique in function from all other tissue cells, they do
With Disclosure of Recently Met Benchmarks for Its Adult Tissue Stem Cell Counting Technology, Asymmetrex Targets Applications to Enable Gene-Editing Therapies Yesterday, tissue stem cell biotechnology start-up company Asymmetrex, LLC posted results on its website from the most recently completed benchmark studies for its computer simulation technology for determining the number of stem cells in